Twitter Beğeni Hilesi

Forschende des #UKEHamburg zeigen: Die kathetergestützte Therapie der Aortenklappenstenose ist dem operativen Klappenersatz auch bei jüngeren Patient:innen mit niedrigem und mittlerem Operationsrisiko ebenbürtig. Mehr Infos: t1p.de/2tws4

Huge win for #TAVR over #SAVR in pts w/ severe aortic stenosis at low or intermediate surgical risk in the DEDICATE trial! DZHK Germany University Center of Cardiovascular Science (UCCS) Deutsche Gesellschaft für Kardiologie Young DGK #CardioTwitter NEJM

Next up at #ACC24 is a big one: #TAVR vs SAVR among low-risk patients. Moritz Seiffert presented data showing TAVR was noninferior to SAVR after 1 year - in fact, it was linked to many benefits. A variety of TAVR valves were used as opposed to focusing on one manufacturer/design.

DEDICATE: 🔑TAVR vs SAVR in real-world low-risk population 🔑All TAVR valves included 🔑Death/stroke at 1 year 47% lower in TAVR group 🔑Driven by death 🔑Cohort will be followed for 5 years #acc24 American College of Cardiology ACC Media Center Moritz Seiffert

#ACC24: #TAVR linked to lower 1-year mortality, stroke rates than SAVR in low-risk patients #cardiology #cardiotwitter ACC Media Center American College of Cardiology Moritz Seiffert ow.ly/XFh250RaBRG

Stefan Blankenberg brings you insights on the DEDICATE-DZHK6 trial at #ACC24   #ESCTVOnTheRoad

🚨Most excited about the results of our industry-independent DEDICATE trial presented by Moritz Seiffert at #ACC24 and NEJM, impressively demonstrating non-inferior safety of #TAVI versus #SAVR in lower risk patients. ❤️‍🩹DZHK Germany University Center of Cardiovascular Science (UCCS) UKE Hamburg nejm.org/doi/full/10.10…

Gratulation an Moritz Seiffert und alle Beteiligten für die erfolgreiche Durchführung dieser wegweisenden Studie, welche komplett industrie-unabhängig durch die DZHK Germany und Deutsche Herzstiftung gefördert wurde. 👏

Original Article: Transcatheter or Surgical Treatment of Aortic-Valve Stenosis (DEDICATE-DZHK6) nej.md/3TLx8MT Editorial: Another Early Win for TAVI in Low-Risk Patients nej.md/3J5F7j5 American College of Cardiology #ACC24

Die Ergebnisse der #DEDICATE-DZHK6-Studie zeigen, dass der kathetergestützte Aortenklappenersatz für jüngere Niedrigrisikopatienten eine gleichwertige Alternative zum chirurgischen Eingriff darstellen kann. Pressemitteilung: herzmedizin.de/meta/presse/ak… DZHK Germany #DGK #DGKPresse

#ACC24 Round Up: Ten Original Articles were simultaneously published in NEJM and presented at this year’s American College of Cardiology Scientific Sessions in Atlanta. View the full thread for all American College of Cardiology articles and bookmark this post for future reference.

🚨#EAPCI elections ending in 4 days🚨 ‼️Your vote shapes our future of #EAPCI‼️ So vote for: ➡️President-elect ➡️Treasurer ➡️Secretary ➡️Nominating Committee Check your 📧 (29th March) for details and cast your vote now. Let’s make a difference together....🗳️❗️

In DEDICATE-DZHK6 trial for low/intermediate surgical risk and severe symptomatic AS, risk of all-cause death or stroke was non-inferior in TAVR (using any contemporary device) vs. SAVR. Download trial slides here: shorturl.at/kyAW4

Dr. Moritz Seiffert and I discuss results of the DEDICATE-DZHK6 trial for severe symptomatic AS in low-intermediate risk patients randomized to TAVR (using any device at operator discretion) vs. SAVR. Watch full interview here

🫀 #TAVR lifetime management including the brand new DEDICATE DZHK6 data presented at 20th North German Heart Days 👉 DEDICATE: Another early win for #TAVI in low risk patients 👉 Lifetime management: The first cut is the deepest Moritz Seiffert Holger Thiele DZHK Germany

Next issue of #CardioNews 10.05.2024 Focus on #lipid management, #CardioCT, heart and pregnancy, sleep apnoe and #obesity and #heartfailure, lots of studies, discussions and more. Thanks to #MeinradGawaz, Deutsche Gesellschaft für Kardiologie, Springer Medizin and all authors for hard work Just #Heartwork:)

A randomized trial that enrolled pts with severe aortic stenosis at low or intermediate surgical risk showed that transcatheter aortic-valve implantation was noninferior to surgical aortic-valve replacement at 1 year. Full DEDICATE-DZHK6 trial results: nej.md/3TLx8MT

🔔#Webinar Alert: Freuen Sie sich auf Episode 6 unserer Reihe "Let's discuss strategy!" mit Prof. Moritz Seiffert, PD Dr. Luise Gaede und Prof. tommaso gori . Praxisfall "Kalk³" im Fokus! Jetzt ansehen: 📺 herzmedizin.de/fuer-aerzte-un… #Herzmedizinde #DGK #BNK

🔔 #Webinar Alert: Freuen Sie sich auf Episode 6 unserer Reihe "Let's discuss strategy!" mit Prof. Moritz Seiffert , PD Dr. Luise Gaede und Prof. tommaso gori. Praxisfall "Kalk³" im Fokus! Jetzt ansehen: 📺 herzmedizin.de/fuer-aerzte-un… #Herzmedizinde #DGK #BNK

Left Main PCI with Intracoronary Imaging Guidance x.com/i/broadcasts/1…